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Arsenic Can Induce DNA
Damage at Pathologically
Meaningful Concentrations 
Arsenic is recognized to be a nonmutagenic
carcinogen because previous studies have
indicated that arsenite induces DNA damage
only at very high concentrations that are not
pathologically meaningful. However, recent
studies have shown that formamidopyrimi-
dine–DNA glycosylase (Fpg) and proteinase
K (PK) markedly increase the number of
DNA strand breaks (DSB) in arsenite-treated
cells (1). Using Fpg-incorporated comet
assay, oxidative DNA damage was detected in
human vascular smooth muscle cells treated
with 1 µM arsenite for 4 hr (2) and in human
lymphocytes treated with 10 µM arsenite for
2 hr (3). By incorporating Fpg and PK into
the comet assay, DSB were detected in the
human leukemia cell line HL60 treated with
0.25 µM arsenite for 4 hr (1). These concen-
trations of arsenic are comparable with the
report that individuals in Inner Mongolia,
China, who continued drinking well water
containing high concentrations of inorganic
arsenic (0.41 µg/mL) have a mean blood con-
centration of total arsenic of 42.1 ng/mL
(about 0.56 µM) (4). The findings that Fpg
and PK can markedly increase DSB in arsen-
ite-treated cells indicate that arsenite induces
DNA adducts rather than DSB directly.
During the cellular DNA repair process,
because DSB appear only temporarily on the
incision of adducts and are rejoined immedi-
ately, the level of DSB will be low at any
given time point. This is most likely the rea-
son that low levels of DSB were detected in
previous studies. Thus, detection of arsenite-
induced DSB using the standard comet assay
or alkaline elution without enzyme digestion
is inadequate. To reveal the maximum level
of DNA adducts with enzyme digestion, it is
desirable to sample the cells immediately after
arsenite treatment. This is to minimize cellu-
lar excision activity and maintain the true
level of DNA adducts. 
Recent signal transduction research has
indicated that arsenic might act on signaling
pathways to regulate cell proliferation (5–7).
These results point to the possibility that
arsenic may induce cancer via an epigenetic
mechanism. However, the significance of
these results may be questioned, as the data
were derived from experiments using very
high concentrations of arsenic. Many experi-
ments were performed using arsenite concen-
trations ranging from 10 µM to several
hundred µM, and nontarget cells were used.
Under our experimental conditions, among
the various cell types listed in Table 1, NB4
cells are most sensitive to arsenite in terms of
cytotoxicity. A 4-hr 0.25-µM arsenite treat-
ment induces DNA damage but does not
affect cell viability (1). A 72-hr, 0.25-µM
arsenite treatment does not reduce cell
survival, whereas a 72-hr, 2-µM arsenite
treatment does. This suggests that arsenite
can induce DNA damage at noncytotoxic
concentrations. On the other hand, arsenic
does not appear to induce signiﬁcant mutage-
nesis at endogenous loci at high levels of cell
survival (8,9). One of the main types of DNA
adduct digested by Fpg is 8-oxoguanine,
which induces G:C→ T:A transversions (10).
We still cannot explain why arsenite can
induce oxidized bases when it is not very
mutagenic. More experiments are therefore
needed to demonstrate that a genetic or epi-
genetic mechanism, or both, are involved in
arsenic-associated carcinogenesis.
Oxidative DNA Adducts
Are Predominant and
Prevalent 
Fpg protein cleaves oxidative bases
such as 8-oxoguanine, 5-hydroxycytosine,
5-hydroxyuracil, 2,6-diamino-4-hydroxy-
5-N-methylformamidopyrimidine, and
4,6-diamino-5-formamidopyrimidne (11).
Endonuclease III (EnIII ) can also cleave
many pyrimidine derivatives, including
thymine glycol, 5,6-dihydrothymine,
5-hydroxy dihydrothymine, 5-hydroxycyto-
sine, 5-hydroxyuracil, and uracil glycol (12).
These two enzymes revealed higher levels of
DSB than did PK (13). The results presented
in Table 1 further indicate that Fpg digestion
enhanced DSB production in all arsenite-
treated human cells examined, whereas PK
enhanced DSB production in arsenite-treated
leukemia cells HL60 and NB4 and Chinese
hamster ovary cells but not in human umbili-
cal vein endothelial cells, human vascular
smooth muscle cells, or human skin fibrob-
lasts. Because oxidative DNA adducts were
predominant in terms of relative quantity and
prevalence in different cell types, we may
conclude that oxidative DNA damage is the
predominant type of DNA damage in arsen-
ite-treated human cells. Alternatively, the
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in all arsenite-treated human cells examined. DNA–protein cross-links were also detected in arsen-
ite-treated NB4 and HL60 cells. In human umbilical vein endothelial cells, the induction of oxi-
dized guanine products by arsenite was sensitive to inhibitors of nitric oxide (NO) synthase but
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DNA damage revealed by Fpg and EnIII
digestion may come from arsenite inhibition
of the excision of endogenous oxidative DNA
damage (14). However, this notion is not
supported by the observation that sequential
digestion of untreated cells with EnIII, Fpg,
and PK did not give significant amounts of
DSB (15).
Arsenite Induces Oxidized
Guanine Products via Nitric
Oxide and/or Reactive 
Oxygen Species
The X-ray–hypersensitive Chinese hamster
ovary cells XRS5, which are deficient in
antioxidant enzymes such as catalase and glu-
tathione peroxidase, are also highly sensitive
to arsenite in terms of micronucleus induc-
tion (16). Moreover, catalase and glutathione
peroxidase decrease, whereas their inhibitors
increase, micronuclei induction in arsenite-
treated XRS5 cells. These results suggest that
reactive oxygen species (ROS) are involved in
arsenite genotoxicity in XRS5 cells.
However, in normal Chinese hamster ovary
cells, the arsenite-induced micronuclei, DSB,
poly(adenosine diphosphate-ribosylation),
and nicotinamide adenine dinucleotide
depletion are suppressible by superoxide dis-
mutase and inhibitors of nitric oxide (NO)
synthase, suggesting the involvement of NO
and/or peroxynitrite in arsenite genotoxicity
(17,18). This notion is also supported by the
observation that in bovine aortic endothelial
cells, treatment with arsenite increases nitrite
production, whereas treatment with cad-
mium increases cellular hydrogen peroxide
(H2O2) levels (19). The arsenite-induced
DSB can be decreased by NO synthase
inhibitors, superoxide scavengers, and perox-
ynitrite scavengers, and increased by superox-
ide generators and NO generators. On the
other hand, the cadmium-induced DSB can
be modulated by various oxidant modulators
but not by NO synthase inhibitors. These
results suggest that whereas cadmium
induces DSB via the superoxice anion radical
(O2
•–), H2O2, and •OH, arsenite seems to
increase NO, which then reacts with O2
•– to
produce peroxynitrite and cause DNA dam-
age. Thus, although ROS are involved in
arsenite-induced DSB in XRS5 cells, NO
and/or peroxynitrite seem to be involved in
arsenite-induced DSB in normal Chinese
hamster ovary cells and bovine aortic
endothelial cells. To conﬁrm this notion fur-
ther, we tested the effect of NO synthase
inhibitors and ROS modulators on arsenite-
induced DSB in a variety of mammalian
cells. The results presented in Table 2 indi-
cate that the arsenite-induced DSB were sup-
pressible by NO synthase inhibitors in
human umbilical vein endothelial cells,
human leukemia cell lines HL60 and NB4,
and bovine aortic endothelial cells but not in
human vascular smooth muscle cells. On the
other hand, the arsenite-induced DSB were
sensitive to ROS modulators in human vas-
cular smooth muscle cells, human leukemia
cell lines HL60 and NB4 but not in human
umbilical vein endothelial cells and bovine
aortic endothelial cells. These results conﬁrm
that the arsenite-induced DSB can come
from either NO or ROS, or both, depending
on the cell type examined. 
Interestingly, although arsenite and 3-mor-
pholinosydnonimine (a peroxynitrite-generat-
ing agent) induce DNA damage via NO
and/or peroxynitrite, and cadmium and H2O2
induce DSB via oxygen radicals, treatment
with all of these three agents induces Fpg-
digestible adducts (19). These results suggest
that NO, peroxynitrite, and H2O2 are all capa-
ble of inducing oxidized guanine products.
This notion is further supported by the obser-
vation that in human umbilical vein endothe-
lial cells, the level of arsenite-induced oxidized
guanine products was reduced by NO synthase
inhibitors but not by catalase. On the other
hand, in human vascular smooth muscle cells
the level of arsenite-induced oxidized guanine
products was reduced by catalase but not by
NO synthase inhibitors, and in HL60 cells the
level of arsenite-induced oxidized guanine
products was reduced by both catalase and
NO synthase inhibitors (Figure 1).
Arsenite May Induce DNA
Damage via Hypochlorous
Acid 
In vascular smooth muscle cells, arsenite
seems to activate NADH oxidase to produce
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Table 1. Effects of Fpg and proteinase K digestion on arsenite-induced DNA strand breaks.
NaAsO2 treatment Fold of DSBa
Cell type for 4 hr (µM) Fpg PK
Human umbilical vein endothelial cells 2 3.7 1.0
Human vascular smooth muscle cells 1 3.2 1.0
Human leukemia cells, HL60 0.25 3.1 7.0
Human leukemia cells, NB4 0.25 2.5 4.4
Human ﬁbroblasts 2 1.9 1.0
Chinese hamster ovary cells 0.25 2.8 1.6
aComet moment of Fpg or PK digested/comet moment of sham digested.
Table 2. Effects of modulators on arsenite-induced DBS.a
Calcium modulators NO synthase inhibitors ROS modulators Myeloperoxidase inhibitors
Cell type A B C D E F
Human umbilical vein endothelial cells ↓↑ ↓ =
Human vascular smooth muscle cells = ↓
Human leukemia cells, HL60 ↓↑ ↓ ↓ ↑ ↓
Human leukemia cells, NB4 ↓↑ ↓ ↓ ↑ ↓
Bovine aortic endothelial cells ↓ ==
Abbreviations: ↓, decreased; ↑ , increased; =, ineffective. aCells were incubated for 4 hr in arsenite with or without modulator. The modulators were (A) 10 µM 1,2-bis(2-
aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid tetrakis(acetoxymethyl ester), and 10 µM Quin2; (B) 10 µM A23187; (C) 25 µM S-methyl-L-thiocitrulline (MTC) or 50 µM Nω -nitro-L-argi-
nine methyl ester (NAME); (D) 100 µg/mL catalase; (E) 0.5 µM diethyldithiocarbarmic acid; and (F) 50 µM 4-aminobenzoic acid hydrazide or 50 µM salicylhydroxamic acid.
Human umbilical vein endothelial cells
R
e
l
a
t
i
v
e
 
o
x
i
d
i
z
e
d
 
g
u
a
n
i
n
e
 
l
e
v
e
l
(
c
o
m
e
t
 
m
o
m
e
n
t
)
Human vascular
smooth muscle cells
Human leukemia
cell line HL60
Human umbilical
vein endothelial cells
*
*
*
*
*
*
As
As + NAME
As + MTC
As + catalase
20
10
0
30
20
10
0
8
4
0
Figure 1. Effects of NO synthase inhibitors and ROS
modulators on arsenite-induced oxidized guanine
products in human cells. Human umbilical vein
endothelial cells, human vascular smooth muscle
cellss and cells of the human leukemia cell line
HL60 were treated with 2 µM sodium arsenite for 4
hr, or sodium arsenite plus 10 µM NAME, 40 µM
MTC, or 800 U/mL catalase for 4 hr. The DSB were
analyzed by comet assay with or without Fpg
digestion. The comet moments of Fpg digested
were subtracted by the comet moments without
enzyme digestion and presented as relative level of
oxidized guanine products. *p < 0.05, with modula-
tors versus without modulators.Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 755
superoxide and cause oxidative DNA damage
because extract from arsenite-treated cells
showed an increased capacity to produce
superoxide when NADH was given, and the
superoxide production as well as DSB were
both suppressed by transfecting antisense
oligonucleotides of p22phox, an essential com-
ponent of NADH oxidase (2). A well-known
oxidative DNA damage pathway is that super-
oxide is converted to H2O2 by superoxide dis-
mutase, and H2O2 can then react with Fenton
metal ions to produce hydroxyl radicals that
can cause oxidative DNA damage. However,
H2O2 can also cause oxidative DNA damage
through the production of hypochlorous acid,
a less well-known pathway. In the presence of
chloride ions, which are abundant in plasma,
H2O2 and myeloperoxidase can generate
hypochlorous acid, causing oxidative DNA
damage (20,21). Because myeloperoxidase
protein is actively expressed in HL60 cells
(22,23), we tested the possibility that this
pathway may exist in these cells. The results
indicate that myeloperoxidase inhibitors can
indeed effectively suppress arsenite-induced
DSB (Table 2).
Arsenite-Induced Nitric
Oxide Seems to be Calcium
Dependent 
In bovine aortic endothelial cells and Chinese
hamster ovary cells, treatment with arsenite
increases the production of NO (18,19). In
Chinese hamster ovary cells, the arsenite-
induced NO production is sensitive to calcium
modulators. Because the arsenite-induced DSB
were sensitive to NO synthase inhibitors and
calcium modulators, it seems that arsenite may
increase NO production through a calcium-
dependent pathway. We still know very little
about how arsenite induces NO production.
Arsenite Induces Oxidized
Guanine Products and
DNA–Protein Cross-Links 
via the Same Pathways
Digestion with PK also increases DSB sub-
stantially in arsenite-treated cells. The DSB
released by PK have been referred to as
DNA–protein cross-links (24). It seems as if
these DSB had already existed and were
bound by proteins. It is not known whether
these DNA–protein cross-links are the same as
those revealed by the technique of potas-
sium–sodium dodecyl sulfate (K-SDS) precip-
itation (25). Although we have concluded that
Fpg-digestible adducts are greater in quantity
and more prevalent in different cell types than
PK-digestible adducts in arsenite-treated cells,
the arsenite-induced Fpg- and PK-digestible
adducts were both sensitive to modulators of
NO, oxidant, myeloperoxidase, and calcium
in HL60 and NB4 cells (1). We therefore
propose identical pathways for the induc-
tion of oxidative DNA and DNA–protein
cross-links on treatment with arsenite
(Figure 2). An immediate question raised is,
if arsenite induces oxidized guanine prod-
ucts and DNA–protein cross-links via the
same pathway, why does arsenite induce
oxidized guanine products in all the cell
types and DNA–protein cross-links in only
some cell types?
Arsenite-Induced Nitric
Oxide and Reactive Oxygen
Species May Not Attack
DNA Only
In addition to oxidative DNA damage, NO,
peroxynitrite, and ROS also attack macromol-
ecules such as lipids and proteins. There is
increasing evidence to support the notion that
these molecules interfere with signal transduc-
tion pathways and modulate transcription fac-
tors. They have also been implicated in the
multistage carcinogenic process, including car-
cinogen activation, DNA damage, and tumor
promotion, and also in various human dis-
eases. Therefore, arsenic-induced NO, peroxy-
nitrite, and ROS may also cause human
disorders via pathways other than oxidative
DNA damage.
Arsenite Toxicology 
Is Cell Speciﬁc
The results presented in Table 1 indicate that
the induction of DNA–protein cross-links by
arsenite is not a generalized phenomenon.
Moreover, although arsenite induction of oxi-
dized guanine products was shown to be a
generalized phenomenon, the pathways could
be different in different cell types (Figure 1).
Because the sensitivity and the mechanism of
arsenic intoxication are cell specific, it is
important that target tissues and target cells
are used for investigations. It is also important
that pathologically or pharmacologically
meaningful concentrations of arsenic are used
because in most cases we are dealing with a
chronic effect rather than acute toxicity. 
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